XM tillhandahåller inte tjänster till personer bosatta i USA.

Wall Street gains as investors bet on second Trump term



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall Street gains as investors bet on second Trump term</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Trump Media, crypto stocks, prison operators jump

Goldman Sachs, BlackRock edge higher after results

Macy's falls after ending discussions with Arkhouse and Brigade

Health insurance stocks gain

Indexes up: Dow 0.50%, S&P 0.42%, Nasdaq 0.51%

Updated at 9:49 a.m. ET/ 1349 GMT

By Lisa Pauline Mattackal and Ankika Biswas

July 15 (Reuters) -The Dow hit a record high in Wall Street's upbeat trading on Monday, on a greater chance of presidential candidate Donald Trump winning a second term after surviving an assassination attempt, while interest-rate cut hopes also aided sentiment.

Under Trump, markets expect a hawkish trade policy and looser regulations over issues from climate change to cryptocurrency.

Online betting site PredictIt showed bets of an election win for Trump at 66 cents, up from Friday's 60 cents, with a victory for Joe Biden at 26 cents.

"In a Republican administration, you'll see a lower tax policy, lower regulatory policy... that's typically good for stocks. We're seeing some of that in terms of forward looking expectations from investors at this point," said Chris Zaccarelli, chief investment officer for Independent Advisor Alliance.

Trump-linked stocks soared, with Trump Media & Technology Group DJT.O, software firm Phunware PHUN.O and video-sharing platform Rumble RUM.O jumping between 6% and 32%.

Crypto stocks also leapt as bitcoin BTC= rose to a two-week high. Coinbase Global COIN.O, Marathon Digital holdings MARA.O and Riot Platforms RIOT.O advanced between 5.3% and 8.2%.

Other stocks that are expected to benefit from Trump's second term also climbed, with Gunmaker Smith & Wesson SWBI.O and prison operator GEO Group GEO.N gaining 12.6% and 9.4%, respectively.

The Dow hit a record high, boosted by a 2% gain in UnitedHealth UNH.N as health insurers also jumped on a likely Trump win.

The small-cap Russell 2000 .RUT gained 1.2% to its highest since January 2022, in continued evidence of broad-based market gains.

Investors priced in an 88% odd of a 25-basis-point rate cut by September and two cuts for 2024, according to LSEG data, even though the Fed's last set of economic projections had indicated only one rate cut this year.

Rate cut hopes aided Friday's strong rally, which saw the Dow and S&P 500 touch intraday record highs after cooler-than-expected inflation data, and the Russell 2000 notch its best week since November.

Comments from Federal Reserve Chairman Jerome Powell and San Francisco Fed President Mary Daly, expected later on Monday, will be parsed for clues on their assessment of last week's inflation data.

At 9:49 a.m. ET, the Dow Jones Industrial Average .DJI was up 201.52 points, or 0.50%, at 40,202.42, the S&P 500 .SPX was up 23.67 points, or 0.42%, at 5,639.02, and the Nasdaq Composite .IXIC was up 93.90 points, or 0.51%, at 18,492.34.

As the quarterly corporate earnings season ramps up this week, it remains to be seen if megacaps can justify their high valuations.

Among megacaps, Apple AAPL.O advanced 1.8% to all-time high after Morgan Stanley added it to its "top pick" list, while Tesla TSLA.O jumped 4.8%.

Leading sectoral gainers was the S&P 500 tech index .SPLRCT. Financials index .SPSY also rose 0.8%, with Goldman Sachs GS.N hitting a record-high after second-quarter profit more than doubled.

Macy's shares M.N slumped 15.3% after the company terminated buyout discussions with Arkhouse Management and Brigade Capital.

Advancing issues outnumbered decliners by a 1.42-to-1 ratio on the NYSE and by a 1.59-to-1 ratio on the Nasdaq.

The S&P index recorded 31 new 52-week highs and one new low, while the Nasdaq recorded 96 new highs and 15 new lows.



Reporting by Lisa Mattackal and Ankika Biswas in Bengaluru; Editing by Shounak Dasgupta and Shinjini Ganguli

</body></html>

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.